Oxidative imbalance in bipolar disorder subtypes: A comparative study

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 6, 2009, Pages 1070-1074

  Yumru, Mehmet ^a   Savas, Haluk A ^a   Kalenderoglu, Aysun ^a   Bulut, Mahmut ^a   Celik, Hakim ^b   Erel, Ozcan ^b  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

Author keywords

Bipolar disorder; Oxidative stress; Total antioxidant status; Total oxidant status

Indexed keywords

ANTIOXIDANT;

ADULT; AEROBIC METABOLISM; ANTIDEPRESSANT INDUCED MANIA; ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOPHYSIOLOGY;

ADULT; ANTIOXIDANTS; BIPOLAR DISORDER; FEMALE; FREE RADICALS; HUMANS; MALE; OXIDANTS; OXIDATIVE STRESS; YOUNG ADULT;

EID: 67651092093     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.06.005     Document Type: Article

References (38)

1. Akiskal H.S., and Pinto O. The evolving bipolar spectrum. Prototypes I, II, III, and IV. Psychiatr Clin North Am 22 (1999) 517-534
2. Andreazza A.C., Kauer-Sant'anna M., Frey B.N., Bond D.J., Kapczinski F., Young L.T., et al. Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord 111 (2008) 135-144
3. American Psychiatric Association: Diagnostic and statistical manual of mental disorders 4th edition, 2004. American Psychiatric Association, Washington D.C.
4. Berk M., Ng F., Dean O., Dodd S., and Bush A.I. Glutathione: a novel treatment target in psychiatry. Trends Pharmacol Sci 29 (2008) 346-351
5. Berk M., Copolov D.L., Dean O., Lu K., Jeavons S., Schapkaitz I., et al. N-acetyl cysteine for depressive symptoms in bipolar disorder-a double-blind randomized placebo-controlled trial. Biol Psychiatry 64 (2008) 468-475
6. Bulut M., Selek S., Gergerlioglu H.S., Savas H.A., Yilmaz H.R., Yuce M., et al. Malondialdehyde levels in adult attention-deficit hyperactivity disorder. J Psychiatry Neurosci 32 (2008) 435-438
7. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37 (2004) 112-119
8. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37 (2004) 277-285
9. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38 (2005) 1103-1111
10. Frey B.N., Andreazza A.C., Kunz M., Gomes F.A., Quevedo J., Salvador M., Goncalves C.A., Kapczinski F., et al. Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 283-285
11. Gergerlioglu H.S., Savas H.A., Bulbul F., Selek S., Uz E., and Yumru M. Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 697-702
12. Guemouri L., Artur Y., Herbeth B., Jeandel C., Cuny G., and Siest G. Biological variability of superoxide dismutase, glutathione peroxidase and catalase in blood. Clin Chem 37 (1991) 1932-1937
13. Guy W. Assessment Manual for Psychopharmacology - Revised. Rockville, MD, U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs (1976) 218-222
14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
15. Herken H., Akyol O., Yilmaz H.R., Tutkun H., Savas H.A., Ozen M.E., et al. Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatment. Hum Psychopharmacol 21 (2006) 53-59
16. Herken H., Gurel A., Selek S., Armutcu F., Ozen M.E., Bulut M., et al. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res 38 (2007) 247-252
17. Hoekstra R., Fekkes D., Pepplinkhuizen L., Loonen A.J., Tuinier S., and Verhoeven W.M. Nitric oxide and neopterin in bipolar affective disorder. Neuropsychobiology 54 (2006) 75-81
18. Kosecik M., Erel O., Sevinc E., and Selek S. Increased oxidative stress in children exposed to passive smoking. Int J Cardiol 100 (2005) 61-64
19. Kuloglu M., Atmaca M., Tezcan E., Ustundag B., and Bulut S. Antioxidant enzyme and malondialdehyde levels in patients with panic disorder. Neuropsychobiology 46 (2002) 186-189
20. Kuloglu M., Ustundag B., Atmaca M., Canatan H., Tezcan A.E., and Cinkilinc N. Lipid peroxidation and antioxidant enzyme levels in patient with schizophrenia and bipolar disorder. Cell Biochem Funct 20 (2002) 171-175
21. Kunz M., Gama C.S., Andreazza A.C., Salvador M., Ceresér K.M., Gomes F.A., et al. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 1677-1681
22. Machado-Vieira R., Andreazza A.C., Viale C.I., Zanatto V., Cereser Jr. V., da Silva Vargas R., et al. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Lett 421 (2007) 33-36
23. Ng F., Berk M., Dean O., and Bush A.I. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 21 (2008) 1-26
24. Sadeghipour H., Ghasemi M., Nobakht M., Ebrahimi F., and Dehpour A.R. Effect of chronic lithium administration on endothelium-dependent relaxation of rat corpus cavernosum: the role of nitric oxide and cyclooxygenase pathways. BJU Int 99 (2007) 177-182
25. Savas H.A., Herken H., Yurekli M., Uz E., Tutkun H., Zoroglu S.S., et al. Possible role of nitric oxide and adrenomedullin in bipolar affective disorder. Neuropsychobiology 45 (2002) 57-61
26. Savas H.A., Gergerlioglu H.S., Armutcu F., Herken H., Yilmaz H.R., Kocoglu E., et al. Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes. World J Biol Psychiatry 7 (2006) 51-55
27. Selek S., Savas H.A., Gergerlioglu H.S., Bulbul F., Uz E., and Yumru M. The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. J Affect Disord 107 (2008) 89-94
28. Selek S., Savas H.A., Gergerlioglu H.S., Bulut M., and Yilmaz H.R. Oxidative imbalance in adult attention deficit/hyperactivity disorder. Biological Psycho 79 (2008) 256-259
29. Sogut S., Zoroglu S.S., Ozyurt H., Yilmaz H.R., Ozugurlu F., Sivasli E., et al. Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clin Chim Acta 331 (2003) 111-117
30. Tamada R.S., Issler C.K., Amaral J.A., Sachs G.S., and Lafer B. Treatment emergent affective switch: a controlled study. Bipolar Disord 6 (2004) 333-337
31. Yanik M., Vural H., Kocyigit A., Tutkun H., Zoroglu S.S., Herken H., et al. Is the arginine-nitric oxide pathway involved in the pathogenesis of schizophrenia?. Neuropsychobiology 47 (2003) 61-65
32. Yanik M., Vural H., Tutkun H., Zoroglu S.S., Savas H.A., Herken H., et al. The role of the arginine nitric oxide pathway in the pathogenesis of bipolar affective disorder. Eur Arch Psychiatry Clin Neurosci 254 (2004) 43-47
33. Yanik M., Erel O., and Kati M. The relationship between potency of oxidative stress and severity of depression. Acta Neuropsychiatrica 16 (2004) 200-203
34. Yao J.K., Reddy R., McElhinny L.G., and van Kammen D.P. Effects of haloperidol on antioxidant defense system enzymes in schizophrenia. J Psychiatr Res 32 (1998) 385-391
35. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133 (1978) 429-435
36. Yu Y.W., Chen T.J., Wang Y.C., Liou Y.J., Hong C.J., and Tsai S.J. Association analysis for neuronal nitric oxide synthase gene polymorphism with major depression and fluoxetine response. Neuropsychobiology 47 (2003) 137-140
37. Zoroglu S.S., Herken H., Yurekli M., Uz E., Tutkun H., Savas H.A., et al. The possible pathophysiological role of serum nitric oxide and adrenomedullin in schizophrenia. J Psych Research 36 (2002) 309-315
38. Zoroglu S.S., Yurekli M., Meram I., Sogut S., Tutkun H., Yetkin O., et al. Pathophysiological role of nitric oxide and adrenomedullin in autism. Cell Biochem Funct 21 (2003) 55-60